Search Results for: "UK - Department for International Development "
To enable CDC to scale up its activity of investing and lending to support the building of businesses in developing countries, to create jobs and make a lasting difference to people’s lives in some of the world's poorest places. CDC is DFID’s main vehicle for investing in private companies in Africa and South Asia. CDC encourages capital investments from other private investors by being a first mover, demonstrating to other investors that commercial returns are possible in these frontier markets, and by sharing risk and expertise. The additional equity from DFID will enable CDC to meet demand for capital in its target markets and allow CDC to sustain a higher volume of more developmental investments across priority regions and business sectors
The United Kingdom's Contribution to the European Development Fund (EDF) for Aid under the Cotonou Agreement. This project was approved before the referendum on the UK’s membership of the EU. Work is now under way to understand the implications of leaving the EU for the UK’s development work
UK contribution to the 18th Replenishment of the World Bank International Development Association (IDA 18)
To reduce poverty by enabling the World Bank to provide grants and low-interest loans that enhance economic opportunities and tackle poverty in poor countries.
Multilateral Debt Relief Initiative (MDRI) Debt Relief to World Bank's International Development Association (IDA)UK Department for International Development
UK contributions to compensate IDA the costs of foregone debt service payments under the Multilateral Debt Relief Initiative (MDRI)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
UK investment in the Global Fund 2020-2022 to reduce transmission and mortality for HIV AIDS, tuberculosis and malaria through treatments, diagnostics and preventive technologies and related servicesUK Department for International Development
To tackle the immediate impact of the three most deadly infectious diseases - HIV AIDS, tuberculosis and malaria - and put the international community on the right track to end the three diseases as epidemics by 2030, and achieve universal health coverage.
To tackle the immediate impact of the three most deadly infectious diseases – HIV/AIDS, tuberculosis and malaria – and put the international community on the right track to end the three diseases as epidemics by 2030.
CEPI’s mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. The budget presented in this activity includes all investments + operating expenses and financial costs. • CFP1 on priority pathogens for EIDs: Launched January 2017 for the diseases Lassa, Nipah and MERS. The decision on priority diseases departed from pathogens identified by the WHO Blueprint for Action, followed by an in-depth assessment by the SAC. In recommending priority diseases to the CEPI Board, the SAC applied criteria related to 1) public health impact (potential of outbreak, transmissibility, burden of disease) and 2) feasibility (current scientific knowledge, pipeline candidates available). • CFP2 on platform technologies: Launched October 2017 to enable rapid vaccine development against both known and unknown pathogens that trigger infections with epidemic potential. A requirement is to produce sufficient vaccine doses to impact an emerging outbreak and that the platform demonstrates versatility one of the priority pathogens from the WHO Blueprint list. • CEPI’s third call for proposals (CfP3i) was for the development of human vaccines against Rift Valley fever and Chikungunya diseases. Rift Valley fever disease is included among the WHO R&D Blueprint list of priority pathogens in 2018, while Chikungunya is deemed to present a major public health risk where further R&D is needed. The call for proposals closed on March, 2019. • In addition CEPI has made calls for Biological standards and assays, Data collection and Scientific research. • In 2020 CEPI launched a new call for proposals to develop vaccines against novel coronavirus, COVID-19. CEPI will strive to include more details the coming months and years.
Gavi supports vaccine delivery in 68 of the world's poorest countries reaching 60% of the world's birth cohort. Gavi immunises children against vaccine preventable diseases including measles, rubella, meningitis, cervical cancer, pneumonia and diarrhoea. Gavi has played a significant role in the recent halving of global child mortality. Over the 2016 to 2020, Gavi will fully deliver the UK target to immunise 76 million children and save 1.4 million lives. Gavi targets reaching those in hard to reach areas, the poorest, and the most marginalised. Gavi has a major global market shaping role for vaccines, negotiating lower prices for low-income countries, and incentivising new vaccines such as for Ebola and Malaria.
Support to the multilateral Climate Investment Funds (CIFs), four funding windows supporting country-led investments in low carbon, climate-resilient developmentUK Department for International Development
To support development and poverty reduction through environmental protection, and help developing countries respond to climate change
To improve access to medicines, diagnostics and preventative items for people affected by HIV/AIDS, TB and malaria in lower income countries, by fast-tracking the introduction of promising new health solutions, and shaping the market for quality health products and expanding access to better, more affordable treatments and technologies aimed at tackling the three diseases and their related co-morbidities.
This activity includes incoming transactions for the COVID-19 response. For more details, please follow the link to the COVID-19 SITUATION page which can be found in “Documents”.
To help approximately three million South Sudanese by providing critical life-saving support and helping people to better cope with shocks from conflict, drought and flooding. This programme aims to save the lives of an estimated two million people who will receive at least one form of humanitarian assistance; and build the capacity of an estimated one million people to recover and cope better with shocks. Over six years this programme will provide food, shelter and access to water and health services to millions of vulnerable people, including women and children.
To provide core funding support to seven UN agencies – Central Emergency Response Fund (CERF); Office for the Coordination of Humanitarian Affairs (OCHA); United Nations High Commissioner for Refugees (UNHCR); UN Children’s Emergency Fund (UNICEF); World Food Programme (WFP); World Health Organisation (WHO); and the International Organisation of Migration (IOM) to support a strengthened humanitarian response and a more efficient, effective and transparent system. These UK funds will enable these UN agencies to respond rapidly to urgent humanitarian needs and shore-up operations in neglected or protracted Crises.
To improve the lives of the Afghan people by providing financial support to improve the Government of Afghanistan’s capability to implement development projects and reforms. This will benefit people in all provinces of Afghanistan by improving access to basic services, infrastructure, governance and community representation. This contributes to MDGs 1-5 through a range of interventions, and will remain the main mechanism for coordinated donor support to Afghanistan for many years to come.
Contributing to economic and social development of Africa's 38 poorest countries across the period 2015-2017. The thirteenth replenishment of the African Development Fund aligns itself with the African Development Bank's Ten year Strategy and will focus on two objectives to improve the quality of Africa’s growth: inclusive growth, and the transition to green growth. It will focus on the five core operational priorities of infrastructure development, regional integration, private sector development, governance and accountability and skills and technology with special emphasis given togender, fragile states, agriculture and food
To meet the contraceptive needs of over 20 million women per year; to reduce unintended pregnancies and maternal deaths; to improve maternal, newborn and child health, and to contribute to universal health coverage. This will be achieved by funding activities to improve the availability, quality, supply and access to key reproductive health commodities, including for those in hard to reach areas. This will support women's rights and the 2030 agenda.
The objective of the programme is to ensure that the UN system is fit for purpose to support implementation of the 2030 Agenda, ensuring delivery of priorities as outlined in the Department’s Single Departmental Plan strategic objectives, and underpinned by the UK Aid Strategy and UK National Security Strategy of: strengthening global peace, security and governance; strengthening resilience and response to crises; promoting global prosperity; tackling extreme poverty and helping the world’s most vulnerable.
Increased responsible private sector participation in sustainable infrastructure in poorer developing countries through increased flows of private capital & expertise.This will benefit an additional 105.1 million people by the end of 2015.